Research Analysts Set Expectations for MAZE FY2024 Earnings
Maze Therapeutics, Inc. (NASDAQ:MAZE – Free Report) – Analysts at Leerink Partnrs issued their FY2024 EPS estimates for shares of Maze Therapeutics in a research note issued on Tuesday, February 25th. Leerink Partnrs analyst J. Schwartz expects that the company will earn ($4.93) per share for the year. Leerink Partnrs currently has a “Strong-Buy” rating […]
Maze Therapeutics, Inc. (NASDAQ:MAZE – Free Report) – Analysts at Leerink Partnrs issued their FY2024 EPS estimates for shares of Maze Therapeutics in a research note issued on Tuesday, February 25th. Leerink Partnrs analyst J. Schwartz expects that the company will earn ($4.93) per share for the year. Leerink Partnrs currently has a “Strong-Buy” rating […]
